Click on headlines below to download research
Termination of coverage
Termination of coverage - Datron | 06/04/2022
Edison Investment Research is terminating coverage on: • 2G Energy (2GB) • Apontis Pharma (APPH) • Artec technologies (A6T) • Beta…
Benefiting from returning demand
Datron | 03/09/2021
A strong year-on-year rebound in Datron’s H121 figures reflects the continuous recovery of economic conditions and customer confidence. After posting…
Recovering after a challenging FY20
Datron | 17/05/2021
Datron’s FY20 results were negatively affected by the market slowdown triggered by COVID-19 (sales down 22% y-o-y to €42.1m and EBIT down 45%…
Market headwinds persist
Datron | 03/09/2020
Datron’s subdued performance in H120 (sales down 17% y-o-y to €22m, and EBIT down 82% y-o-y) reflects the challenging market situation exacerbated…
Facing a distressed market
DATRON | 19/05/2020
After two years of solid growth, Datron recorded a slight drop in full-year sales in FY19 and a significant decline in EBIT (down by a quarter, year-on-year).…
Fighting its corner
DATRON | 16/09/2019
DATRON has accompanied news of 23% lower EBIT in H119 with a full-year profit warning. While the former was not unexpected, given a bumper comparative,…
DATRON delivers
DATRON | 22/05/2019
More good news from DATRON as confirmation of targeted growth in 2018 (revenue up 11% at enhanced like-for-like margin) has been accompanied by similarly…
Investment pays off
DATRON | 13/09/2018
DATRON has built on a strong start to the year to deliver positive H118 results. While not strictly comparable owing to first group accounts, EBIT all…
Building on success
DATRON | 29/06/2018
Confirmation of a “very successful” start to 2018 is reassuring, given a softening in H217 after marked progress in the preceding half. Albeit…